Page 54 - Read Online
P. 54

Review  |  Open Access

                             Microbiome Research Reports


                                      Poznyak et al. Microbiome Res Rep. 2026;5:3      DOI:10.20517/mrr.2025.69



               An overview of the role of the gut microbiota in
               rheumatoid arthritis




               Anastasia V. Poznyak , Aleksey A. Vatlin , Vsevolod V. Pavshintsev , Nikita A. Mitkin , Olga N. Maltseva ,
                                                                                                      3
                                                                        2
                                                                                      2
                                 1
                                                 2
               Aleksandra S. Utkina , Alexander N. Orekhov 1
                                 4
               Keywords:
               Rheumatoid arthritis,
               autoimmunity,
               inflammation, microbiome
               Citation: Poznyak AV,
               Vatlin AA, Pavshintsev VV,
               Mitkin NA, Maltseva ON,
               Utkina AS, Orekhov AN. An
               overview of the role of the
               gut microbiota in
               rheumatoid arthritis.
               Microbiome Res Rep.
               2026;5:3.
               https://dx.doi.org/10.20517
               /mrr.2025.69

               Received: 14 Jul 2025
               First Decision: 12 Nov  Abstract
               2025
               Revised: 28 Jan 2026  Rheumatoid   arthritis   (RA)   is   a   chronic   autoimmune   disease   preceded   by   a   prolonged
               Accepted: 6 Feb 2026  preclinical   phase   marked   by   the   emergence   of   autoantibodies   and   mucosal   immune
               Published: 9 Mar 2026  dysregulation. Evidence from human studies and animal models consistently demonstrates
                                   that gut microbiota dysbiosis contributes to this transition, particularly through impaired
               Academic Editors:
               Miguel Gueimonde,   intestinal   barrier   function,   activation   of   pro-inflammatory   pathways,   and   molecular
               Sin-Hyeog Im        mimicry. Specific taxa - including Prevotella copri, Collinsella aerofaciens, and reductions in
               Copy Editor:        butyrate-producing   bacteria   -   have   been   linked   to   heightened   systemic   inflammation,
               Shu-Yuan Duan       increased   T   helper   17   responses,   and   the   generation   of   RA-associated   autoantibodies.
               Production Editor:
               Shu-Yuan Duan       Current  research  also  indicates  that  anti-rheumatic  medications  such  as  methotrexate,
                                   sulfasalazine, and minocycline produce measurable shifts in gut microbial composition,
                                   suggesting   that   microbiota-drug   interactions   may   influence   treatment   response.
                                   Therapeutic approaches aimed at modifying gut ecology - including dietary interventions,
                                   prebiotics,   probiotics,   and   fecal   microbiota   transplantation   -   show   early   potential   in
                                   restoring   microbial   balance,   improving   intestinal   barrier   integrity,   and   reducing
                                   inflammatory   markers,   although   evidence   in   the   preclinical   RA   stage   remains   limited.
                                   Additionally,   emerging   data   highlight   the   importance   of   intestinal   autophagy   and




               1 Institute for Atherosclerosis Research, Moscow 121609, Russia.
               2 Institute of Ecology, Рeoples’ Friendship University of Russia (RUDN University), Moscow 117198, Russia.
               3 Institute of Experimental Medicine, Saint Petersburg 197022, Russia.
               4 Department of Commodity Expertise and Customs Business, Plekhanov Russian University of Economics, Moscow 115054, Russia.

               Correspondence to: Anastasia V. Poznyak, Institute for Atherosclerosis Research, Moscow 121609, Russia. E-mail: tehhy_85@mail.ru




               www.oaepublish.com                                    Submit a Manuscript: https://ucenter.oaepublish.com
   49   50   51   52   53   54   55   56   57   58   59